The artificial heart-- past, present, and future.

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Advanced congestive heart failure (CHF) carries a high mortality rate, with heart transplantation being the preferred treatment.
• The demand for heart transplants significantly exceeds donor availability, creating a critical need for alternative solutions.
• Current treatments, including left ventricular assist devices (LVADs), offer temporary support but have limitations.

Purpose of the Study:

• To review the advancements in artificial heart technology for end-stage heart failure.
• To highlight the potential of the AbioCor total artificial heart as a viable treatment option.
• To discuss the future prospects and challenges of total artificial heart implantation.

Main Methods:

• Review of existing literature on artificial heart devices, including historical context and recent innovations.
• Analysis of the technical features and implantation success of the AbioCor total artificial heart.
• Discussion of the clinical implications and patient outcomes associated with total artificial heart therapy.

Main Results:

• The AbioCor represents a significant advancement as the first fully implantable replacement heart with an internal battery system.
• This device eliminates the need for external power connections, improving patient mobility and quality of life.
• Previous total artificial hearts, like the Jarvik-7, faced challenges with patient quality of life and complications.

Conclusions:

• The total artificial heart, exemplified by the AbioCor, shows promise in extending and improving the lives of heart failure patients.
• Further technical improvements and adaptation to various body sizes are necessary for widespread adoption.
• Total artificial heart technology is evolving rapidly, offering a future solution for end-stage heart failure.